The average one-year price target for GoodRx Holdings (NasdaqGS:GDRX) has been revised to $3.17 / share. This is an increase ...

GoodRx Holdings, Inc. (NASDAQ:GDRX) was among the stocks on Jim Cramer’s radar as he highlighted the importance of lower ...

Quarterly filings reveal markedly different revenue trajectories and margin profiles for these two healthcare platforms. What ...

Most of the list features brand-name drugs, competing with far cheaper generic versions from other manufacturers, such as the ...

Guidance changed upward: Q4 2025 guidance was “$750 million to $780 million” revenue and “at least $230 million” adjusted EBITDA, while Q1 2026 guidance moved to “$765 million to $785 million” and “at ...

The new TrumpRx program relies partly on connecting consumers with discount coupons offered by drugmakers. For insured ...

GoodRx’s introduction of an oral semaglutide access pathway for type 2 diabetes patients reflects broader changes in how ...

GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today announced that it is providing access to self-pay pricing for Novo Nordisk's Ozempic® pill (oral semaglutide), ...

If increased transparency isn’t the answer, what could meaningfully lower patients’ out-of-pocket costs? Reduced prices of ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

President Donald Trump has repeatedly said his deals with drugmakers would bring down prescription drug prices in the U.S. But a report released by Senate Democrats finds prices have continued to ...